Cantargia AB

Industry / private company


Location: Lund, Sweden (SE) SE

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis (2024) Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau AR, Li YN, Györfi AH, et al. Journal article Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis (2022) Gronberg C, Rattik S, Kunz M, Thoung Trinh-Minh , Tran Manh C, Zhou X, Skoog P, et al. Conference contribution